Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mukoviszidose Institut is the research and development subsidiary of the German Cystic Fibrosis Association (Mukoviszidose e.V.), serving as a central hub for cystic fibrosis research in Germany. The institute manages the German Cystic Fibrosis Registry, a comprehensive database that tracks patient outcomes to improve clinical care and facilitate longitudinal studies. It provides essential infrastructure for clinical trials, acting as a specialized contract research organization (CRO) that connects pharmaceutical companies with clinical centers. Additionally, the institute is responsible for quality management and the certification of cystic fibrosis care centers to ensure standardized, high-quality treatment across the country.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mukoviszidose Institut.